18.22MMarket Cap-0.25P/E (TTM)
4.2900High3.8200Low190.88KVolume4.0800Open3.9800Pre Close794.55KTurnover6.54%Turnover RatioLossP/E (Static)4.59MShares16.940052wk High1.14P/B11.58MFloat Cap1.520152wk Low--Dividend TTM2.92MShs Float105.4000Historical High--Div YieldTTM11.81%Amplitude1.5200Historical Low4.1620Avg Price1Lot Size
Senti Biosciences Stock Forum
Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics
Monday, 16th December at 8:00 am
– Dose-finding clinical trial in China designed to evaluate safety and preliminary anti-tumor activity of SN301A (SENTI-301A manufactured in China) in hepatocellular carcinoma ("HCC") –
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ: SNTI) ("Senti ...
🔥👹👊 GHOST (STOCK, ETF, BITCOIN...) = BLOCK SHORT = CHIF LAO = THE MORE YOU BUY THE MORE YOU LOSS, TRADE ONE WAY TO HELL, ARE YOU SMART ? 🤔
HOW DO YOU WANT TO PUNISH CHEATERS ? 👽
📊⚡️📊
👀 👀 👀
No comment yet